Markets:

Overview

News

Currencies

International

Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

22.32 -0.07 (-0.31%)

Streaming Delayed Price Updated: 10:01 AM EST, Feb 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

February 13, 2026

A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a...

Via StockStory

Topics Economy

2 Small-Cap Stocks to Target This Week and 1 Facing Challenges

February 11, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Cash-Producing Stocks Walking a Fine Line

February 08, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

1 Profitable Stock for Long-Term Investors and 2 We Avoid

February 05, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Healthcare Technology for Providers Stocks Q3 Recap: Benchmarking Astrana Health (NASDAQ:ASTH)

February 02, 2026

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers.

Via StockStory

Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

February 01, 2026

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and...

Via StockStory

3 Low-Volatility Stocks with Open Questions

January 28, 2026

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Why Privia Health (PRVA) Shares Are Plunging Today

January 27, 2026

Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) fell 6.5% in the morning session after concerns swept the healthcare provider sector as industry giant UnitedHealth Group warned of...

Via StockStory

Topics Initial Public Offering

1 Growth Stock Set to Flourishand 2 That Underwhelm

January 26, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Topics Artificial Intelligence

Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

January 25, 2026

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx (NASDAQ:GDRX) and its peers.

Via StockStory

2 Healthcare Stocks to Keep an Eye On and 1 We Ignore

January 12, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only...

Via StockStory

Topics Stocks

1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Avoid

December 31, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

What's going on in today's pre-market session ↗

December 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

December 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with...

Via StockStory

1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down

December 14, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

3 Reasons to Sell PRVA and 1 Stock to Buy Instead

December 11, 2025

Privia Health has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.6% to $24.88 per share while the index has gained...

Via StockStory

Topics Stocks Supply Chain

1 Cash-Producing Stock to Target This Week and 2 Facing Challenges

December 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

1 Safe-and-Steady Stock to Target This Week and 2 We Find Risky

December 07, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Topics Bonds

Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz

November 25, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers.

Via StockStory

CONMED, Select Medical, BrightSpring Health Services, Privia Health, and RadNet Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

3 Small-Cap Stocks We Find Risky

November 18, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

3 Russell 2000 Stocks with Warning Signs

November 16, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

5 Revealing Analyst Questions From Privia Health’s Q3 Earnings Call

November 13, 2025

Privia Health’s third quarter results surpassed Wall Street’s expectations, yet the market responded negatively—a reaction management attributed in part to uncertainties surrounding the sustainability...

Via StockStory

Topics Earnings

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

November 11, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest

November 11, 2025

Via StockStory

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

PRVA Q3 Deep Dive: Acquisition and Value-Based Care Expansion Shape Outlook

November 07, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year...

Via StockStory

Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q3 2025 Results, Raises Full-Year Guidance ↗

November 06, 2025

Privia Health's Q3 2025 earnings beat on EPS and raised full-year guidance, driving a positive market reaction despite a revenue miss.

Via Chartmill

Topics Earnings

Privia Health (NASDAQ:PRVA) Surprises With Strong Q3

November 06, 2025

Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year revenue...

Via StockStory

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.